Bank Of America Corp Adc Therapeutics Sa Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Bank Of America Corp holds 1,216,418 shares of ADCT stock, worth $3.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,216,418
Previous 1,193,847
1.89%
Holding current value
$3.71 Million
Previous $5.36 Million
28.3%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ADCT
# of Institutions
80Shares Held
52.9MCall Options Held
300KPut Options Held
59.3K-
Redmile Group, LLC San Francisco, CA15.3MShares$46.6 Million3.15% of portfolio
-
Prosight Management, LP Dallas, TX9.57MShares$29.2 Million9.45% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.32MShares$13.2 Million0.33% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$10.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.97MShares$9.04 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $237M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...